Eton Pharmaceutcials Inc.

Eton Pharmaceutcials Inc. is a real momentum stock, the stock has been booming recently, and may keep doing so in the near future. Eton Pharmaceutcials Inc. has good growth characteristics. Eton Pharmaceutcials Inc. is a mediocre stock to choose.
Log in to see more information.
Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug pro...

News

After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar
After Leaping 26% Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Are Not Flying Under The Radar

Simply Wall St The Eton Pharmaceuticals, Inc. ( NASDAQ:ETON ) share price has done very well over the last month, posting an excellent...\n more…

Q3 2024 Earnings Estimate for Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Issued By HC Wainwright
Q3 2024 Earnings Estimate for Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Issued By HC Wainwright

Ticker Report Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities researchers at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for Eton Pharmaceuticals in a research report...\n more…

Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ETON)
Equities Analysts Offer Predictions for Eton Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ETON)

Zolmax Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2024 earnings estimates for shares of Eton Pharmaceuticals in a note issued to...\n more…

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expected to Post FY2025 Earnings of $0.31 Per Share
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Expected to Post FY2025 Earnings of $0.31 Per Share

Ticker Report Eton Pharmaceuticals, Inc. (NASDAQ:ETON - Free Report) - Equities research analysts at HC Wainwright issued their FY2025 EPS estimates for Eton Pharmaceuticals in a note issued to investors on...\n more…

Eton Pharmaceuticals: A Strong Buy on Niche Market Leadership and Robust Growth Prospects
Eton Pharmaceuticals: A Strong Buy on Niche Market Leadership and Robust Growth Prospects

TipRanks Financial Blog Eton Pharmaceuticals (ETON) has received a new Buy rating, initiated by H.C. Wainwright analyst, Swayampakula Ramakanth. Swayampakula Ramakanth has...\n more…

Eton Pharmaceuticals assumed with a Buy at H.C. Wainwright
Eton Pharmaceuticals assumed with a Buy at H.C. Wainwright

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…